Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
References
Link | Resource |
---|---|
https://bishopfox.com | Third Party Advisory |
https://know.bishopfox.com/advisories/solismed-critical | Exploit Third Party Advisory |
https://www.bishopfox.com/blog/news-category/advisories/ | Third Party Advisory |
https://www.solismed.com/ | Product |
https://bishopfox.com | Third Party Advisory |
https://know.bishopfox.com/advisories/solismed-critical | Exploit Third Party Advisory |
https://www.bishopfox.com/blog/news-category/advisories/ | Third Party Advisory |
https://www.solismed.com/ | Product |
Configurations
History
21 Nov 2024, 04:29
Type | Values Removed | Values Added |
---|---|---|
References | () https://bishopfox.com - Third Party Advisory | |
References | () https://know.bishopfox.com/advisories/solismed-critical - Exploit, Third Party Advisory | |
References | () https://www.bishopfox.com/blog/news-category/advisories/ - Third Party Advisory | |
References | () https://www.solismed.com/ - Product |
Information
Published : 2019-12-12 14:15
Updated : 2024-11-21 04:29
NVD link : CVE-2019-15931
Mitre link : CVE-2019-15931
CVE.ORG link : CVE-2019-15931
JSON object : View
Products Affected
intesync
- solismed
CWE
CWE-22
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')